Financial Post
Dr. Heidi Wang Accepts Award on Behalf of OBI Pharma at ADC Asia Congress 2025 and Gives a Presentation TAIPEI, Taiwan, March 12, 2025 (GLOBE NEWSWIRE) — At the ADC Asia Congress 2025 held today (3/12) in Singapore, OBI Pharma (4174.TWO) was honored with the “Most Promising ADC Clinical Candidate in Taiwan” award…
Read More
OBI Pharma Receives ‘Most Promising ADC Clinical Candidate in Taiwan’ Award
GlobeNewswire
15:26
Dr. Heidi Wang Accepts Award on Behalf of OBI Pharma at ADC Asia Congress 2025 and Gives a Presentation TAIPEI, Taiwan, March 12, 2025 (GLOBE NEWSWIRE) — At the ADC Asia Congress 2025 held today (3/12) in Singapore, OBI Pharma (4174.TWO) was honored with the “Most Promising ADC Clinical Candidate in Taiwan” award…
